Literature DB >> 18208496

Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review.

P De1, E Roy, J-F Boivin, J Cox, C Morissette.   

Abstract

The use of blood-contaminated drug preparation equipment is believed to be associated with the transmission of hepatitis C virus (HCV) among injection drug users (IDUs), but the extent of HCV infection risk is unclear. The objective of this review was to appraise the evidence regarding HCV incidence associated with the use of drug preparation equipment such as drug mixing containers, filters and water. In June 2007, cohort and case-control studies examining the association of HCV incidence with the sharing of drug preparation equipment were identified by searching electronic reference databases as well as the reference lists of published papers. Ten studies (seven cohort and three nested case-control) met the inclusion criteria for the review. The relative risk of HCV infection associated with drug preparation equipment were mainly between 2.0 and 5.9; however, the precision of the estimates from individual studies were marked by wide confidence intervals. Few studies exist to allow an adequate assessment of the individual contributions of containers, filters and water to HCV incidence. The major methodological limitations of reviewed studies were short follow-up times, inadequate control of confounders and lack of exclusion of periods when IDUs were not at risk for HCV infection through drug injection. Current evidence implicating the association of drug preparation equipment with HCV incidence is limited by several methodological concerns.

Entities:  

Mesh:

Year:  2008        PMID: 18208496      PMCID: PMC2929252          DOI: 10.1111/j.1365-2893.2007.00942.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  31 in total

1.  Minimising harm from hepatitis C virus needs better strategies.

Authors:  N Crofts; S Caruana; S Bowden; M Kerger
Journal:  BMJ       Date:  2000-10-07

2.  Re: "Risk of hepatitis C virus among young adult injection drug users who share injection equipment".

Authors:  Stephen Koester; Robert Heimer; Anna E Barón; Jason Glanz; Wei Teng
Journal:  Am J Epidemiol       Date:  2003-02-15       Impact factor: 4.897

3.  Association between injection practices and duration of injection among recently initiated injection drug users.

Authors:  Meredith Becker Buxton; David Vlahov; Steffanie A Strathdee; Don C Des Jarlais; Edward V Morse; Lawrence Ouellet; Peter Kerndt; Richard S Garfein
Journal:  Drug Alcohol Depend       Date:  2004-08-16       Impact factor: 4.492

4.  Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users?

Authors:  Farzana Kapadia; David Vlahov; Don C Des Jarlais; Steffanie A Strathdee; Lawrence Ouellet; Peter Kerndt; Edward V Morse E; Ian Williams; Richard S Garfein
Journal:  Epidemiology       Date:  2002-11       Impact factor: 4.822

5.  Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment.

Authors:  Lorna E Thorpe; Lawrence J Ouellet; Ronald Hershow; Susan L Bailey; Ian T Williams; John Williamson; Edgar R Monterroso; Richard S Garfein
Journal:  Am J Epidemiol       Date:  2002-04-01       Impact factor: 4.897

6.  Sharing of drug preparation equipment as a risk factor for hepatitis C.

Authors:  H Hagan; H Thiede; N S Weiss; S G Hopkins; J S Duchin; E R Alexander
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

7.  Detection of antibodies against hepatitis C virus in saliva: a marker of viral replication.

Authors:  S O Cameron; K S Wilson; T Good; J McMenamin; B McCarron; A Pithie; R Fox
Journal:  J Viral Hepat       Date:  1999-03       Impact factor: 3.728

8.  Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China.

Authors:  Rebecca J Garten; Shenghan Lai; Jinbing Zhang; Wei Liu; Jie Chen; David Vlahov; Xiao-Fang Yu
Journal:  Int J Epidemiol       Date:  2004-02       Impact factor: 7.196

9.  Hepatitis C virus seroconversion among young injection drug users: relationships and risks.

Authors:  Judith A Hahn; Kimberly Page-Shafer; Paula J Lum; Philippe Bourgois; Ellen Stein; Jennifer L Evans; Michael P Busch; Leslie H Tobler; Bruce Phelps; Andrew R Moss
Journal:  J Infect Dis       Date:  2002-11-04       Impact factor: 5.226

10.  Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users.

Authors:  Cari L Miller; Caitlin Johnston; Patricia M Spittal; Kathy Li; Nancy Laliberté; Julio S G Montaner; Martin T Schechter
Journal:  Hepatology       Date:  2002-09       Impact factor: 17.425

View more
  21 in total

Review 1.  Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment.

Authors:  Enrique R Pouget; Holly Hagan; Don C Des Jarlais
Journal:  Addiction       Date:  2012-04-17       Impact factor: 6.526

Review 2.  The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review.

Authors:  Michelle Gillies; Norah Palmateer; Sharon Hutchinson; Syed Ahmed; Avril Taylor; David Goldberg
Journal:  BMC Public Health       Date:  2010-11-23       Impact factor: 3.295

3.  Development, validation, and potential applications of the hepatitis C virus injection-risk knowledge scale (HCV-IRKS) among young opioid users in New York City.

Authors:  Kelly Quinn; Chunki Fong; Honoria Guarino; Pedro Mateu-Gelabert
Journal:  Drug Alcohol Depend       Date:  2018-11-28       Impact factor: 4.492

4.  A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs.

Authors:  T Spelman; M D Morris; G Zang; T Rice; K Page; L Maher; A Lloyd; J Grebely; G J Dore; A Y Kim; N H Shoukry; M Hellard; J Bruneau
Journal:  J Epidemiol Community Health       Date:  2015-03-26       Impact factor: 3.710

5.  Potential impact of vaccination on the hepatitis C virus epidemic in injection drug users.

Authors:  Judith A Hahn; Dennis Wylie; Jesse Dill; Maria S Sanchez; James O Lloyd-Smith; Kimberly Page-Shafer; Wayne M Getz
Journal:  Epidemics       Date:  2009-03       Impact factor: 4.396

6.  Taking care of themselves: how long-term injection drug users remain HIV and Hepatitis C free.

Authors:  Peter Meylakhs; Samuel R Friedman; Pedro Mateu-Gelabert; Milagros Sandoval; Nastia Meylakhs
Journal:  Sociol Health Illn       Date:  2015-02-16

Review 7.  Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.

Authors:  Frederick L Altice; Adeeba Kamarulzaman; Vincent V Soriano; Mauro Schechter; Gerald H Friedland
Journal:  Lancet       Date:  2010-07-31       Impact factor: 79.321

8.  Experiences of drug use and ageing: health, quality of life, relationship and service implications.

Authors:  Brenda Roe; Caryl Beynon; Lucy Pickering; Paul Duffy
Journal:  J Adv Nurs       Date:  2010-07-02       Impact factor: 3.187

9.  Self reported health status, and health service contact, of illicit drug users aged 50 and over: a qualitative interview study in Merseyside, United Kingdom.

Authors:  Caryl M Beynon; Brenda Roe; Paul Duffy; Lucy Pickering
Journal:  BMC Geriatr       Date:  2009-10-09       Impact factor: 3.921

10.  A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design.

Authors:  Marie Jauffret-Roustide; Yann Le Strat; Elisabeth Couturier; Damien Thierry; Marc Rondy; Martine Quaglia; Nicolas Razafandratsima; Julien Emmanuelli; Gaelle Guibert; Francis Barin; Jean-Claude Desenclos
Journal:  BMC Infect Dis       Date:  2009-07-16       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.